Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Medical technology & services

Empower Clinics appoints healthcare executive Anthony Tomasello to its board 

"[Tomasello's] invaluable insight, track record and leadership in leading public healthcare companies will be a tremendous asset to support our ambitious growth plans," said Steven McAuley, chairman and CEO of Empower

Empower Clinics Inc. (CSE:CBDT, OTCQB:EPWCF), an integrated healthcare company, has announced the appointment of health executive Anthony Tomasello to its corporate board with immediate effect.

Tomasello is the managing director and partner of iNetworks Opportunity Fund II Advisors, LLC - a private equity general partner and investment firm active since 1999 in the healthcare, life sciences and information technology sectors.

Empower said he brings more than 30 years of healthcare, technology, public markets and commercialization experience to support the growth of the company.

"We're proud and honoured to welcome Anthony to the Empower Clinics team," said Steven McAuley, chairman and CEO of Empower in a statement. "His invaluable insight, track record and leadership in leading public healthcare companies will be a tremendous asset to support our ambitious growth plans.

READ: Empower Clinics announces appointment of Carolyn Shields as senior vice president of Operations for The Medi-Collective (TMC)

“His addition to our team reflects my continued commitment to recruit world class talent who have excelled in growing healthcare businesses within major public companies."

Tomasello has previously served as executive vice president and chief technical officer of NASDAQ-traded Stericycle, Inc., which specializes in regulated services to the healthcare community.

He joined Stericycle in its infancy as a venture capital start-up funded with $200,000 of seed capital and was instrumental in the company's growth to its position as the world's leader in its field with approximately $1.5 billion in sales, an enterprise value of more than $9 billion and more than 10,000 employees.

Prior to Stericycle, Tomasello founded, grew, and then subsequently sold a specialist consulting engineering firm.

He is the holder of multiple domestic and international patents and is a graduate of the University of Pittsburgh in Mechanical Engineering.

He has experience from the boards of public and private companies and non-profit organizations. In his recent tenure, he was the longest-serving member of the Merrill Lynch/Bank of America advisory board.

He is also the chairman and largest individual shareholder of Novian Health, an FDA and EU-approved breast tumor therapy company, where he guides the company’s strategic activities.

As an investor and advisor, Tomasello supports the development of Propel IT, Inc., a predictive data analytics company within the logistics space. He is also a board member of Infrastructure Resources; Vizsafe and Digital Dream Labs, all iNetworks portfolio companies.

"Empower Clinics has laid the foundation to be a powerhouse in integrated healthcare," said Tomasello. "I'm deeply impressed with their focus on integrating the partnerships with pharmacies and the businesses of medical clinics, diagnostic laboratory services and medical devices that make up Empower for the benefit of patients.

“This unique combination of solutions could redefine access to integrated healthcare across North America. I look forward to contributing to Empower's ongoing success and growth," he concluded.

Contact the author at jon.hopkins@proactiveinvestors.com

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK